Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| EXELIXIS, INC. | 25,891 | reported | 27 May 2026 | tx 12+91,001−41,974 |
| Syros Pharmaceuticals, Inc. | 16,000 | reported | 05 Jun 2024 | tx 9+110,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | EXELIXIS, INC. | 8,367 | 0.00 USD | |
| 13 Feb 2026 | SALE | EXELIXIS, INC. | 3,856 | 43.79 USD | |
| 02 Jun 2025 | SALE | EXELIXIS, INC. | 18,834 | 42.74 USD | |
| 02 Jun 2025 | SALE | EXELIXIS, INC. | 4 | 43.67 USD | |
| 29 May 2025 | GRANT_AWARD | EXELIXIS, INC. | 9,812 | 0.00 USD | |
| 14 Feb 2025 | SALE | EXELIXIS, INC. | 3,856 | 35.04 USD | |
| 14 Feb 2025 | EXERCISE | EXELIXIS, INC. | 7,712 | 23.24 USD | |
| 14 Feb 2025 | SALE | EXELIXIS, INC. | 7,712 | 35.01 USD | |
| 14 Feb 2025 | EXERCISE | EXELIXIS, INC. | 7,712 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 4,000 | 0.00 USD | |
| 05 Jun 2024 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 31 May 2024 | GRANT_AWARD | EXELIXIS, INC. | 18,838 | 0.00 USD | |
| 05 Jan 2024 | GRANT_AWARD | EXELIXIS, INC. | 15,424 | 0.00 USD | |
| 05 Jan 2024 | GRANT_AWARD | EXELIXIS, INC. | 30,848 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 4,000 | 0.00 USD | |
| 01 Jun 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 16 Sept 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 8,000 | 0.00 USD | |
| 16 Sept 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 12,000 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 08 Jun 2021 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 08 Sept 2020 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 35,000 | 0.00 USD | deriv |